Unknown

Dataset Information

0

Torreya nucifera seed oil improves 3T3-L1 adipocyte differentiation.


ABSTRACT:

Background

Adipose tissue is a critical regulator of lipid storage and endocrine function. Impairment of the recruitment of new adipocytes in the adipose tissue is associated with ectopic fat accumulation, diabetes and insulin resistance. Torreya nucifera, an evergreen conifer that grows in warm temperate climates, has been found to exert beneficial effects against inflammation, infection and diabetes. However, the molecular mechanisms responsible for these effects at the cellular level remain unknown. This study aimed to investigate effects of Torreya nucifera seed oil (TNSO) on 3T3-L1 adipocyte differentiation and its underlying regulatory mechanism.

Methods

To investigate the effects of TNSO on adipocyte differentiation, 3T3-L1 cells were induced to differentiate for 5 days in the presence of 0.75 μL/mL TNSO. Oil Red O staining and an assay for intracellular triglyceride were performed to determine the extent of lipid accumulation in 3T3-L1 cells. To elucidate the underlying mechanism of TNSO, adipogenic gene expression was analyzed using quantitative real-time PCR. Moreover, we monitored TNSO-derived activation of PPARγ and STAT3 with 3T3-L1 reporter cell lines engineered to secrete Gaussia luciferase upon the interaction of a transcription factor to its DNA binding element.

Results

Oil Red O staining revealed that TNSO improved the differentiation of 3T3-L1 preadipocytes into mature adipocytes. The mRNA levels of adipogenic genes, including adiponectin, fatty acid synthase (FAS) and adipocyte fatty acid-binding protein (FABP4), were upregulated and intracellular triglyceride levels increased upon TNSO treatment. We also established that adipocyte differentiation was improved by TNSO-derived activation of PPARγ and STAT3.

Conclusions

Our results suggest that TNSO improves adipocyte differentiation by regulating the activation of adipogenic transcription factors, indicating that it may serve as a potential treatment strategy for adipocyte dysfunction.

SUBMITTER: Koh E 

PROVIDER: S-EPMC8496151 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6277307 | biostudies-literature
| S-EPMC4116336 | biostudies-literature
2005-01-01 | E-MARS-2 | biostudies-arrayexpress
| S-EPMC7424414 | biostudies-literature
| S-EPMC5736245 | biostudies-literature
| S-EPMC3622581 | biostudies-literature
| S-EPMC3983240 | biostudies-literature
| S-EPMC5137149 | biostudies-literature
| S-EPMC3063807 | biostudies-literature
2023-02-13 | PXD039532 | Pride